{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/icatibant.json","peptide":{"slug":"icatibant","name":"Icatibant","url":"https://peptidescanner.com/peptides/icatibant/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":64,"entries":[{"objectId":"story:clinicaltrials-gov-nct00097695-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00097695","domain":"Clinical trials","dateInSource":"2021-06-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00097695-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct00097695-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct00097695-icatibant-v1","contentSha256":"806d64ecba11170b07e8c00ef99aa7741ba7264f01490526036a6dbe52c4923d"},{"objectId":"story:clinicaltrials-gov-nct00223704-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00223704","domain":"Clinical trials","dateInSource":"2013-11-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00223704-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct00223704-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct00223704-icatibant-v1","contentSha256":"b2526670d40d2e6a7ddb26a663f6a2e64d4371b938d9ea8f9fc30e6c87bf2b3e"},{"objectId":"story:clinicaltrials-gov-nct00500656-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00500656","domain":"Clinical trials","dateInSource":"2021-06-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00500656-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct00500656-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct00500656-icatibant-v1","contentSha256":"6581d62bf29baa08180c9aeb8a1ed57d4aa4a50c161db89da47f528a831d1ce8"},{"objectId":"story:clinicaltrials-gov-nct00912093-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00912093","domain":"Clinical trials","dateInSource":"2021-06-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00912093-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct00912093-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct00912093-icatibant-v1","contentSha256":"d3431b11ed94dc66289b9e329ce1b4146fed98b78e757e5e1b414e8f60f5a680"},{"objectId":"story:clinicaltrials-gov-nct00997204-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00997204","domain":"Clinical trials","dateInSource":"2021-06-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00997204-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct00997204-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct00997204-icatibant-v1","contentSha256":"e6942bfa55b531de49a39a8bc9e93469ee8840975ac0cd467bc3a77459448118"},{"objectId":"story:clinicaltrials-gov-nct01386658-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01386658","domain":"Clinical trials","dateInSource":"2021-06-08","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01386658-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct01386658-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct01386658-icatibant-v1","contentSha256":"6b83c361ccb29dc558c7de4cbed35af451b58f21ff3c8d4533bff88201d71694"},{"objectId":"story:clinicaltrials-gov-nct01457430-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01457430","domain":"Clinical trials","dateInSource":"2016-10-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01457430-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct01457430-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct01457430-icatibant-v1","contentSha256":"6e0f74a0dd3a20708c51b62c85bffbba130ae1087fcd9b226f92c1a753241dae"},{"objectId":"story:clinicaltrials-gov-nct01919801-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01919801","domain":"Clinical trials","dateInSource":"2021-06-08","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01919801-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct01919801-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct01919801-icatibant-v1","contentSha256":"c8924ccecea6d12b3f9ba129a4880b4248a73b66154a880de37f09c69dfee593"},{"objectId":"story:clinicaltrials-gov-nct02045264-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02045264","domain":"Clinical trials","dateInSource":"2021-06-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02045264-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct02045264-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct02045264-icatibant-v1","contentSha256":"2655211de371a49d282d299474e04c4117013811b45918022ac6a1892c7d90e4"},{"objectId":"story:clinicaltrials-gov-nct03177798-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03177798","domain":"Clinical trials","dateInSource":"2019-10-29","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03177798-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct03177798-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct03177798-icatibant-v1","contentSha256":"d94392dd3d781f84d1629d182a5abc519da7bb2acd22fa25b7edb0eee9eea5fc"},{"objectId":"story:clinicaltrials-gov-nct03888755-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03888755","domain":"Clinical trials","dateInSource":"2021-06-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03888755-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct03888755-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct03888755-icatibant-v1","contentSha256":"dfe93d7f190cf3e3259524eb0770dd1c55cc79c412254df449768ad3ceae93dc"},{"objectId":"story:clinicaltrials-gov-nct04057131-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT04057131","domain":"Clinical trials","dateInSource":"2025-02-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04057131-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct04057131-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct04057131-icatibant-v1","contentSha256":"92b245bcaf091e266036312cdb433f44b025d19b342a877cdad598b7b48be9d8"},{"objectId":"story:clinicaltrials-gov-nct04113109-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT04113109","domain":"Clinical trials","dateInSource":"2026-08-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04113109-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct04113109-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct04113109-icatibant-v1","contentSha256":"9acd1f29f810621845592ccd436e16ba38e26642e79ebed56923e735ea6eb22b"},{"objectId":"story:clinicaltrials-gov-nct04488081-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT04488081","domain":"Clinical trials","dateInSource":"2026-03-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04488081-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct04488081-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct04488081-icatibant-v1","contentSha256":"f66c73bb47953c37c664f0bd0fab8027a9dcb9e82344dc78363fe7445bdc8391"},{"objectId":"story:clinicaltrials-gov-nct04654351-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT04654351","domain":"Clinical trials","dateInSource":"2022-03-29","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04654351-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct04654351-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct04654351-icatibant-v1","contentSha256":"0d972a16e45ccd50134a0642b84f7539a8da59359e270f7d6e6403c1c2c79062"},{"objectId":"story:clinicaltrials-gov-nct04978051-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT04978051","domain":"Clinical trials","dateInSource":"2022-08-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04978051-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct04978051-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct04978051-icatibant-v1","contentSha256":"4b67d46afa3d5426665ed9277934130cbf3e887d34d0e0437f803ea054f2efe1"},{"objectId":"story:clinicaltrials-gov-nct05407597-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT05407597","domain":"Clinical trials","dateInSource":"2023-09-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05407597-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct05407597-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct05407597-icatibant-v1","contentSha256":"7a991dda4af012f101a1b9e82f29a20647ad7bfc40acc3194476c98f31d5a179"},{"objectId":"story:clinicaltrials-gov-nct05509569-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT05509569","domain":"Clinical trials","dateInSource":"2026-08-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05509569-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct05509569-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct05509569-icatibant-v1","contentSha256":"ac60b4e8c593f01a9a13859dcb798d91ef67c2a4ea18f5f318fe53d427b26007"},{"objectId":"story:clinicaltrials-gov-nct05834777-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT05834777","domain":"Clinical trials","dateInSource":"2026-10-22","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05834777-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#clinicaltrials-gov-nct05834777-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#clinicaltrials-gov-nct05834777-icatibant-v1","contentSha256":"8231339b37e2bd18bc31fa9611a049642cd541821903cb23abb180da8ec9afbb"},{"objectId":"story:fda-drugs-anda208317:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application ANDA208317","domain":"Regulatory","dateInSource":"2020-06-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda208317/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#fda-drugs-anda208317-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#fda-drugs-anda208317-v1","contentSha256":"bbd2783e77fa453441044779a2b929949017b669c3e5c452fcf0ac84c9ac5095"},{"objectId":"story:fda-drugs-anda210118:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application ANDA210118","domain":"Regulatory","dateInSource":"2019-07-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda210118/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#fda-drugs-anda210118-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#fda-drugs-anda210118-v1","contentSha256":"0168643d2066c3471de88f35c5c04de89d533b3347ba79dd3c53efd002705ca1"},{"objectId":"story:fda-drugs-anda211021:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application ANDA211021","domain":"Regulatory","dateInSource":"2020-03-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda211021/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#fda-drugs-anda211021-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#fda-drugs-anda211021-v1","contentSha256":"291519116de9000d1cde853bd98a7eead0b94544c583db46ea4964ed6b95cca2"},{"objectId":"story:fda-drugs-anda211501:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application ANDA211501","domain":"Regulatory","dateInSource":"2020-09-02","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda211501/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#fda-drugs-anda211501-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#fda-drugs-anda211501-v1","contentSha256":"03f0220a45389fd204ca9e1b1f95fc9dbd5a46ef55ef8f8116eb6c25c9b66512"},{"objectId":"story:fda-drugs-anda212081:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application ANDA212081","domain":"Regulatory","dateInSource":"2020-12-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda212081/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#fda-drugs-anda212081-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#fda-drugs-anda212081-v1","contentSha256":"ac97a27f050e84c0fc416bc8985a85a0478eb10ea6521cedb3a6922144cb6ccc"},{"objectId":"story:fda-drugs-anda212446:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application ANDA212446","domain":"Regulatory","dateInSource":"2020-07-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda212446/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#fda-drugs-anda212446-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#fda-drugs-anda212446-v1","contentSha256":"728d55e3e6f9edc0d82adf8f50342db2273d8df6b749c0d6de95d70113a8173a"},{"objectId":"story:fda-drugs-anda213054:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application ANDA213054","domain":"Regulatory","dateInSource":"2020-10-05","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda213054/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#fda-drugs-anda213054-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#fda-drugs-anda213054-v1","contentSha256":"bd3650969613e70388c5b9c15fba3f9f728c07303f6a41a0bbfad584597f5ba0"},{"objectId":"story:fda-drugs-anda213222:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application ANDA213222","domain":"Regulatory","dateInSource":"2021-05-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda213222/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#fda-drugs-anda213222-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#fda-drugs-anda213222-v1","contentSha256":"4a2812713dab3ad2a67a039dbb06a262a9fbe1a73cac0b5239482985928a5906"},{"objectId":"story:fda-drugs-anda213521:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application ANDA213521","domain":"Regulatory","dateInSource":"2023-08-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda213521/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#fda-drugs-anda213521-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#fda-drugs-anda213521-v1","contentSha256":"eb9061ebe29943012a2cf8e560064015678c0b4309ac87523fb9cbb2a902b1d0"},{"objectId":"story:fda-drugs-anda213773:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application ANDA213773","domain":"Regulatory","dateInSource":"2024-06-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda213773/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#fda-drugs-anda213773-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#fda-drugs-anda213773-v1","contentSha256":"27d05646943f003ca03c13ed4692ce820d35f9a03e6ee13a534aae92c020fb0f"},{"objectId":"story:fda-drugs-nda022150:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application NDA022150","domain":"Regulatory","dateInSource":"2011-08-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda022150/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#fda-drugs-nda022150-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#fda-drugs-nda022150-v1","contentSha256":"b8e1991583214a4505bb0b89085be91caf1c5d948fe0d0fb84ee03b1ac6b713c"},{"objectId":"story:federal-register-2011-12543:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2011-12543","domain":"Regulatory","dateInSource":"2011-05-23","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2011-12543/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#federal-register-2011-12543-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#federal-register-2011-12543-v1","contentSha256":"bdfa605120b602029299415cfefd4eb56adb831b91a887f5e560e0e9941f2b27"},{"objectId":"story:federal-register-2014-07331:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2014-07331","domain":"Regulatory","dateInSource":"2014-04-02","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2014-07331/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#federal-register-2014-07331-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#federal-register-2014-07331-v1","contentSha256":"df22577ea01d18a804f211ae8d34e80a3afcfed2eae62fa1cf92da3053c4f9b5"},{"objectId":"story:federal-register-2023-04175:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2023-04175","domain":"Regulatory","dateInSource":"2023-03-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2023-04175/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#federal-register-2023-04175-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#federal-register-2023-04175-v1","contentSha256":"22cde7f45a6df00f293b9072551078c9c9a6a7f05a2c16f19c3bd10b0ddb6b09"},{"objectId":"story:federal-register-e7-24812:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice E7-24812","domain":"Regulatory","dateInSource":"2007-12-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-e7-24812/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#federal-register-e7-24812-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#federal-register-e7-24812-v1","contentSha256":"87f96237954434d1cd61134bc3c9fb722e0bb751795dc3c0e5fda1470efd6aa6"},{"objectId":"story:pubmed-pmid-15563238-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant: HOE 140, JE 049, JE049.","domain":"Literature metadata","dateInSource":"2018-10-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15563238-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-15563238-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-15563238-icatibant-v1","contentSha256":"d6615d679531c7a6a54b42fc8c35e35ff25b193e0ff0d83b07899faee49d50ae"},{"objectId":"story:pubmed-pmid-15991885-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant: HOE 140, JE 049, JE049.","domain":"Literature metadata","dateInSource":"2018-10-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15991885-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-15991885-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-15991885-icatibant-v1","contentSha256":"8cfea13093502e91ddb322aac08944d4bee14031217ddd5d61a59852e53c5961"},{"objectId":"story:pubmed-pmid-17418383-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).","domain":"Literature metadata","dateInSource":"2014-11-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-17418383-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-17418383-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-17418383-icatibant-v1","contentSha256":"40bd449bd129d05fa50c101651da65a727c5c864cb53675fae451c61d3dc2975"},{"objectId":"story:pubmed-pmid-20135020-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant for hereditary angioedema.","domain":"Literature metadata","dateInSource":"2025-10-22","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20135020-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-20135020-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-20135020-icatibant-v1","contentSha256":"4ee07d23e72e876d9f0c77f32aa4a615a1cddec8e6ac13a017cda4dbf42af839"},{"objectId":"story:pubmed-pmid-21595592-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant in hereditary angioedema: news and challenges.","domain":"Literature metadata","dateInSource":"2013-11-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-21595592-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-21595592-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-21595592-icatibant-v1","contentSha256":"fb8282b2c8cb71a979a1880f4062609bd81f1b3aa38c6a8493a7365ee3ab1a9d"},{"objectId":"story:pubmed-pmid-21788245-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Management of adult patients with icatibant in hereditary angioedema.","domain":"Literature metadata","dateInSource":"2013-11-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-21788245-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-21788245-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-21788245-icatibant-v1","contentSha256":"0dad858f37f596090c18d2cb9a8073a2cbfff8d576029de00c77aa765819d68c"},{"objectId":"story:pubmed-pmid-22970904-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.","domain":"Literature metadata","dateInSource":"2022-03-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-22970904-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-22970904-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-22970904-icatibant-v1","contentSha256":"0ff75f75c6e963646ad095696de9327eca447a6fe3eedbe7f6c52bf2dfd4c813"},{"objectId":"story:pubmed-pmid-23249729-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant for the treatment of hereditary angioedema.","domain":"Literature metadata","dateInSource":"2017-11-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23249729-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-23249729-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-23249729-icatibant-v1","contentSha256":"33411f8384ceedb0fe97b624b2004e5224e59c8dd44c6448620da300ed5b7269"},{"objectId":"story:pubmed-pmid-24749847-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.","domain":"Literature metadata","dateInSource":"2026-11-08","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-24749847-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-24749847-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-24749847-icatibant-v1","contentSha256":"32513039caf311c8a231a0f0fc8f8efcaec3ce5915667db29f9a46e9613a4df8"},{"objectId":"story:pubmed-pmid-24931134-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"[Prophylactic use of icatibant before tracheal intubation of a patient with hereditary angioedema type III. (A literature review of perioperative management of patients with hereditary angioedema typ…","domain":"Literature metadata","dateInSource":"2016-12-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-24931134-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-24931134-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-24931134-icatibant-v1","contentSha256":"4beb4478e209ca4f492f1e6aeaf07952dd92f3e8912e345d2411d97f59adf419"},{"objectId":"story:pubmed-pmid-27123689-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant as acute treatment for hereditary angioedema in adults.","domain":"Literature metadata","dateInSource":"2017-03-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-27123689-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-27123689-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-27123689-icatibant-v1","contentSha256":"3ec6bae904deccc4589525ce0cd12c6f0d2667ae255f4059f329ab6a53d8dc84"},{"objectId":"story:pubmed-pmid-30651343-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B2 Receptor Antagonist Icatibant Are G Protein Biased Agonists for MRGPRX2 in Mast Cells.","domain":"Literature metadata","dateInSource":"2020-03-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30651343-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-30651343-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-30651343-icatibant-v1","contentSha256":"c284bef45e6990fe86015d60bff4c9a7b61f54f13627626678906426bb0da638"},{"objectId":"story:pubmed-pmid-30849486-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"The identification and chromatographic separation of a new highly analogous impurity of the active pharmaceutical ingredient icatibant.","domain":"Literature metadata","dateInSource":"2019-07-23","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30849486-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-30849486-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-30849486-icatibant-v1","contentSha256":"90ab11d9e66c6095b32e63e6fe3451070197977969e4b0edec31ed91ea0e5600"},{"objectId":"story:pubmed-pmid-32107042-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Angioedema by MDMA mediated by bradykinin. Role of icatibant acetate.","domain":"Literature metadata","dateInSource":"2021-05-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32107042-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-32107042-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-32107042-icatibant-v1","contentSha256":"956ed64ecb42ce58b0309b796cad3de69fe28b65707f49e6f10e6f70d4bfb8ea"},{"objectId":"story:pubmed-pmid-32919903-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks.","domain":"Literature metadata","dateInSource":"2021-09-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32919903-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-32919903-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-32919903-icatibant-v1","contentSha256":"80317a26c66f0e77fefb7f59fc2ada1c1c85da279dd683e0fdd563d033e14c81"},{"objectId":"story:pubmed-pmid-33275101-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Case Report.","domain":"Literature metadata","dateInSource":"2022-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-33275101-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-33275101-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-33275101-icatibant-v1","contentSha256":"a5ab35d53f759115e1a279ce2e3ff0c6ba1ac666bcc455e87855cec3118d3286"},{"objectId":"story:pubmed-pmid-33292436-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Review of icatibant use in the Winnipeg Regional Health Authority.","domain":"Literature metadata","dateInSource":"2024-03-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-33292436-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-33292436-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-33292436-icatibant-v1","contentSha256":"823b43e4788057011bd47854766c1345d473b5542e11c7e70f94954870fa1855"},{"objectId":"story:pubmed-pmid-33738947-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Real-world off-label use of icatibant for acute management of non-hereditary angioedema.","domain":"Literature metadata","dateInSource":"2021-05-31","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-33738947-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-33738947-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-33738947-icatibant-v1","contentSha256":"6c4efff85acbcf45f0481e9ca0181df420366d59f1aeae62b9099b38da817422"},{"objectId":"story:pubmed-pmid-33851451-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema.","domain":"Literature metadata","dateInSource":"2021-10-04","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-33851451-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-33851451-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-33851451-icatibant-v1","contentSha256":"6b77421eea9c16323cd06499735df31fa2f5211de70924074e3071b235d34057"},{"objectId":"story:pubmed-pmid-35275476-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Exceptional treatment of COVID-19 pneumonia with icatibant.","domain":"Literature metadata","dateInSource":"2025-09-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35275476-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-35275476-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-35275476-icatibant-v1","contentSha256":"3880f6fd55a6692900eb84223f340fce0585bedfbefd1d56ee273b3342ece4bf"},{"objectId":"story:pubmed-pmid-35317892-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"How satisfactory is on-demand icatibant from the patients' perspective in real life?","domain":"Literature metadata","dateInSource":"2022-04-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35317892-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-35317892-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-35317892-icatibant-v1","contentSha256":"23df0388dbe149f7993d5e3e338d47d002487acc42121a06f0e7105a866f135d"},{"objectId":"story:pubmed-pmid-36641883-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"In vivo near-infrared fluorescence and SPECT-CT imaging of colorectal Cancer using the bradykinin B2R-specific ligand icatibant.","domain":"Literature metadata","dateInSource":"2026-01-27","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-36641883-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-36641883-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-36641883-icatibant-v1","contentSha256":"adff87288068e5cab6fbcc0bcfd22e064dbcf1d7d271f6302d7ff36a38213c8b"},{"objectId":"story:pubmed-pmid-37067851-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant in viral infections.","domain":"Literature metadata","dateInSource":"2026-01-27","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37067851-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-37067851-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-37067851-icatibant-v1","contentSha256":"b4e11534dc9e32ee84f5e187f9186c5905c586a674d5cc3386cd56e5bba04011"},{"objectId":"story:pubmed-pmid-38142950-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Assessing the performance of new chromatographic technologies for the separation of peptide epimeric impurities: the case of Icatibant.","domain":"Literature metadata","dateInSource":"2026-01-27","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38142950-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-38142950-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-38142950-icatibant-v1","contentSha256":"b4264052697582efe427db167ef0b6807d4603f67e7be533ad59d4eeec921f0b"},{"objectId":"story:pubmed-pmid-40559541-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pathophysiology of COVID-19: A Post Hoc Analysis of the ICAT-COVID Clinical Trial of the Bradykinin Antagonist Icatibant.","domain":"Literature metadata","dateInSource":"2025-06-27","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-40559541-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-40559541-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-40559541-icatibant-v1","contentSha256":"f5e3bb3982d0b61044e5ec3ed377b0e013aeaee07dde8da76161349f04a5421a"},{"objectId":"story:pubmed-pmid-41008531-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant Acts as a Balanced Ligand of MRGPRX2 in Human Skin Mast Cells.","domain":"Literature metadata","dateInSource":"2026-03-29","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41008531-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-41008531-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-41008531-icatibant-v1","contentSha256":"847c07a72ffb31c6784246c100c8ed9a2c060405cfac48bc514f26697b54990a"},{"objectId":"story:pubmed-pmid-41133754-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant Use During Pregnancy: A South African Case Series.","domain":"Literature metadata","dateInSource":"2025-12-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41133754-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-41133754-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-41133754-icatibant-v1","contentSha256":"d2d3cc1d66fc68256bcea7e6e9b648cef6a458200317153063b7777feb7cbd71"},{"objectId":"story:pubmed-pmid-42219034-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib.","domain":"Literature metadata","dateInSource":"2026-07-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42219034-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-42219034-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-42219034-icatibant-v1","contentSha256":"cc24d411b750f026306b7fb43eeac0de25912aa089747ca58078865bc900d424"},{"objectId":"story:pubmed-pmid-42343494-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"Icatibant for acute hereditary angioedema attacks in pediatric patients: A systematized review.","domain":"Literature metadata","dateInSource":"2026-06-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42343494-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-42343494-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-42343494-icatibant-v1","contentSha256":"b0a09ea599db07f046d2f2b24592606f6499e49be790cb1babe00591e81b86a4"},{"objectId":"story:pubmed-pmid-42656409-icatibant:v1","state":"current","stateChangedAt":"2026-11-15","title":"On-demand treatment of icatibant in a patient of hereditary angioedema with KNG1 mutation.","domain":"Literature metadata","dateInSource":"2026-08-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42656409-icatibant/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.json#pubmed-pmid-42656409-icatibant-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/icatibant.md#pubmed-pmid-42656409-icatibant-v1","contentSha256":"ec67b9c46dcfa2dba1df285a36e77eebf01dd001ec12689177c411dd0c65ad3c"}]}
